Revolutionizing Urinary Health: Wearable, Drug-Free Neuromodulation for Incontinence
Vivally is an at-home, non-invasive therapy for urge urinary incontinence and urinary urgency without the need for surgery, implants, or drugs. (Image: Avation Medical)
Surgery- and drug-free at-home wearable neuromodulation represents a huge advancement for a variety of clinical conditions, including overactive bladder syndrome, which affects more than 46 million people in the U.S.
On this episode of Medical Design Briefs’ Podcast, Jill Schiaparelli, CEO of Avation Medical, discusses the first FDA-cleared, non-invasive, closed-loop wearable neuromodulation technology for at-home bladder treatment. From understanding the technology behind it to its real-world impact on patients and clinicians, this podcast uncovers the potential of wearable neuromodulation in revolutionizing the treatment of OAB.
Subscribe to the Medical Design Briefs podcast on Apple Podcasts or Spotify .
Top Stories
Webcasts
Sensor
- SAE Automotive Podcast: Exploring V2X Vehicle Communications with Honda & Miovision Experts
- Blood Pressure Sensor: How It Works & Key Applications
- Graphene‑Based Electronic Tattoo Offers Continuous, Accurate Heart Monitoring for Extended Periods
- Northwestern Engineers Unveil Wearable Mimicking Skin’s Tactile Sensors
- CEVA Launches SensPro2: Seven DSP Cores & Custom ISAs Boost AI and Sensor Performance
- Ohio State Launches First Wearable Sensor for Real-Time Muscle Atrophy Monitoring
- Graphite‑Based Sensor Boosts Sensitivity & Flexibility for Wearable Medical Devices
- Automated Ultrasonic In‑Situ Monitoring for Composite Cure Defect Detection
- LogFire: Rule-Based Runtime Verification for Reliable System Monitoring
- Ultra-Compact Infrared Spectrometer: 2 cm² Chip for Handheld Chemical Analysis